What is Precision Biosystems?
Precision Biosystems is a key player in the life sciences instrumentation market, specializing in the development and manufacturing of automated, cost-effective instruments for critical laboratory processes. Their flagship products include the BlotCycler, which automates the complex immunodetection steps in western blot processing, thereby improving experimental consistency and reproducibility. Complementing this is the Qsep100, a high-resolution capillary gel electrophoresis system designed for precise separation of DNA and RNA fragments. These solutions cater to laboratories seeking to enhance efficiency and reduce operational overhead without compromising the quality of scientific outcomes.
How much funding has Precision Biosystems raised?
Precision Biosystems has raised a total of $30K across 1 funding round:
Debt
$30K
Debt (2021): $30K with participation from PPP
Key Investors in Precision Biosystems
PPP
Public-Private Partnership
What's next for Precision Biosystems?
With the recent influx of substantial expansion capital, Precision Biosystems is poised for accelerated growth. This strategic investment is expected to fuel further product development, enhance manufacturing capabilities, and broaden market reach. The company's focus on automation and affordability positions it well to capture increasing demand from research institutions and diagnostic laboratories worldwide. Future endeavors will likely involve scaling operations to meet growing demand and potentially exploring new applications for their core technologies, solidifying their role as a provider of essential, low-maintenance laboratory tools.
See full Precision Biosystems company page
